PDHX (human, O00330) review notes

Deep research status

just deep-research-falcon human PDHX FAILED in this worktree: the wrapper
scripts/deep_research_wrapper.py hits a runtime TypeError: unsupported operand type(s) for |: 'type' and 'NoneType' at line ~158 (a dict | None default
annotation evaluated at runtime under an incompatible interpreter). No
-deep-research-falcon.md was produced. Per project policy I did NOT fabricate a
-deep-research-*.md. This review is grounded in the UniProt record
(PDHX-uniprot.txt), the seeded GOA, cached publications/PMID_*.md, and the
disorder KB ~/repos/dismech/kb/disorders/Pyruvate_Dehydrogenase_Deficiency.yaml.

Core biology

PDHX = "component X" / E3-binding protein (E3BP). A structural, non-catalytic
subunit of the mitochondrial pyruvate dehydrogenase complex (PDC). Built into the
E2 (DLAT) dodecahedral inner core; its established function is to bind and anchor
the E3 dihydrolipoyl dehydrogenase (DLD) to the E2 core, positioning E3 to
reoxidise the lipoyl arms. Segmented multidomain architecture like E2: N-terminal
lipoyl(-binding) domain (lipoylated at K97), a peripheral subunit-binding domain
(PSBD; the E3-binding domain, residues ~183-220), and a C-terminal E2-like inner
core (I') domain that packs into the E2 60-mer core.

Key evidence

• PMID:9242632
• NOT a functional acetyltransferase: PMID:9242632 => GO:0004742
  (dihydrolipoyllysine-residue acetyltransferase activity) and GO:0016746
  (acyltransferase activity) are homology/family over-annotations. The catalytic
  His is absent -> MARK_AS_OVER_ANNOTATED (not REMOVE for the IDA; keep as
  over-annotated). The IEA family maps => REMOVE-worthy in principle, but per
  policy for IEA I mark over-annotated / modify to the structural role; I use
  MARK_AS_OVER_ANNOTATED for the catalytic MF terms because they are family-fold
  correct but not the true function.
• Structural core: PMID:16263718
• Tethers E3: PMID:19240034 — this is the strongest single
  statement: E3BP is explicitly "noncatalytic".
• E3-binding domain / DLD interaction, mutagenesis hot spot: PMID:16442803.
• Core stoichiometry ~48 E2 + 12 E3BP (or 40/20 reconstituted model): PMID:14638692,
  PMID:19240034, PMID:20361979 (uncached), UniProt SUBUNIT.
• PDHX is a "structural subunit": PMID:25525879.
• PDHX is lipoylated at K97 and is a SIRT4 lipoamidase substrate: PMID:25525879 (SIRT4 removes lipoyl from PDHX peptide); UniProt MOD_RES 97
  N6-lipoyllysine; PTM "Delipoylated at Lys-97 by SIRT4".

Interactions (IPI GO:0005515 protein binding)

• Biologically meaningful: DLD/E3 (P09622) — the anchoring partner; SIRT4 (Q9Y6E7)
  — lipoamidase regulator. These are the real functional interactions but bare
  "protein binding" is uninformative; per curation policy avoid bare protein binding
  and prefer a specific MF. Mark the DLD-supported ones as over-annotated (the
  specific "E3 anchoring" role is captured better by core_functions / structural
  constituent term).
• High-throughput screen hits with no established biological role for PDHX:
  AGTRAP (Q6RW13; PMID:21516116, PMID:25416956, PMID:31515488), CIDEB (Q9UHD4;
  PMID:32296183). These are proteome-scale Y2H / AP-MS maps (PMID:28514442,
  PMID:32296183, PMID:33961781). MARK_AS_OVER_ANNOTATED per policy (not REMOVE for
  IPI experimental).

Localization

Mitochondrial matrix (UniProt SUBCELLULAR LOCATION: Mitochondrion matrix; TRANSIT
1..53). GO:0005739 mitochondrion (IBA/NAS/IDA/HTP) and GO:0005759 mitochondrial
matrix (IEA/TAS) all correct. Matrix is more specific and accurate.

Disease

Pyruvate dehydrogenase E3-binding protein deficiency (PDHXD, MIM:245349;
MONDO:0009503; ORPHA:255182): PDC deficiency with normal E1/E2/E3 activities,
congenital lactic acidosis, hypotonia, psychomotor retardation. Disease gene per
Orphanet [ORPHA:255182 "PDHX | pyruvate dehydrogenase complex component X |
hgnc:21350 | Disease-causing germline mutation(s) in"].

Annotation decisions summary

• GO:0045254 pyruvate dehydrogenase complex (part_of) — ACCEPT (all copies). Core.
• GO:0005759 mitochondrial matrix (located_in) — ACCEPT (most specific CC).
• GO:0005739 mitochondrion — ACCEPT (correct, less specific than matrix); keep.
• GO:0006086 pyruvate decarboxylation to acetyl-CoA — ACCEPT as involved_in/BP
  (PDHX is a required structural subunit of the complex that performs this; IC/IDA
  reasonable). The IEA involved_in and the ComplexPortal IDA are fine.
• GO:0004742 acetyltransferase activity (IDA MGI + IEA ARBA) — MARK_AS_OVER_ANNOTATED:
  catalytic His->Ser, catalysis unlikely (PMID:9242632); E3BP is noncatalytic
  (PMID:19240034). The IDA is likely a legacy family/reconstitution annotation.
• GO:0016746 acyltransferase activity (IEA InterPro) — MARK_AS_OVER_ANNOTATED (same
  reason; broad family term, no catalysis).
• GO:0005515 protein binding (IPI x many) — MARK_AS_OVER_ANNOTATED (bare, uninformative;
  the meaningful DLD/SIRT4 interactions are better captured by structural role).

Core function (MF/role)

Best MF/role term: PDHX acts as a structural constituent that anchors E3(DLD) to the
E2 core. Candidate GO terms:
- GO:0098918 structural constituent of synapse — NO (wrong).
- GO:0005198 structural molecule activity — generic MF, defensible for a scaffold
subunit; check branch.
- "protein-macromolecule adaptor activity" GO:0030674 — anchoring/adaptor MF for
tethering E3 to E2; strong candidate for the "anchor E3 to E2" function.
Will use GO:0030674 (protein-macromolecule adaptor activity) as the MF capturing the
E3-anchoring/scaffold role, plus in_complex GO:0045254, locations GO:0005759.
Verify labels via OLS before finalizing.